- Home
- VINC vs BIOR Comparison
VINC vs BIOR Comparison
Compare VINC & BIOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINC
- BIOR
- Stock Information
- Founded
- VINC 2019
- BIOR 2010
- Country
- VINC United States
- BIOR United States
- Employees
- VINC N/A
- BIOR N/A
- Industry
- VINC Biotechnology: Pharmaceutical Preparations
- BIOR Biotechnology: Pharmaceutical Preparations
- Sector
- VINC Health Care
- BIOR Health Care
- Exchange
- VINC Nasdaq
- BIOR Nasdaq
- Market Cap
- VINC 10.7M
- BIOR 12.6M
- IPO Year
- VINC N/A
- BIOR 2020
- Fundamental
- Price
- VINC $0.30
- BIOR $2.25
- Analyst Decision
- VINC Buy
- BIOR Strong Buy
- Analyst Count
- VINC 2
- BIOR 1
- Target Price
- VINC $2.00
- BIOR $150.00
- AVG Volume (30 Days)
- VINC 354.0K
- BIOR 126.0K
- Earning Date
- VINC 11-12-2024
- BIOR 11-14-2024
- Dividend Yield
- VINC N/A
- BIOR N/A
- EPS Growth
- VINC N/A
- BIOR N/A
- EPS
- VINC N/A
- BIOR N/A
- Revenue
- VINC N/A
- BIOR $860,000.00
- Revenue This Year
- VINC N/A
- BIOR $32,550.00
- Revenue Next Year
- VINC N/A
- BIOR $95.48
- P/E Ratio
- VINC N/A
- BIOR N/A
- Revenue Growth
- VINC N/A
- BIOR 777.55
- 52 Week Low
- VINC $0.29
- BIOR $2.30
- 52 Week High
- VINC $9.37
- BIOR $19.90
- Technical
- Relative Strength Index (RSI)
- VINC 28.28
- BIOR 28.61
- Support Level
- VINC $0.29
- BIOR $2.42
- Resistance Level
- VINC $0.38
- BIOR $3.10
- Average True Range (ATR)
- VINC 0.03
- BIOR 0.34
- MACD
- VINC 0.01
- BIOR -0.02
- Stochastic Oscillator
- VINC 7.00
- BIOR 3.43
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.
About BIOR Biora Therapeutics Inc.
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.